Stockreport

Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S. [Yahoo! Finance]

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)  (FMS) 
Last fresenius medical care ag american depositary shares (each representing 1/2 of an ordinary share) earnings: 7/31 04:03 pm Check Earnings Report
PDF The tocilizumab biosimilar provides increased access and an affordable, high-quality, and safe treatment option for U.S. patients. Excellent performance of the (Bio)P [Read more]